Now I have a thorough understanding of the paper. Let me compose the final consolidated review.

---

## Summary

This paper introduces NN-kNN—a network-based k-nearest neighbors model that is fully interpretable by design (predictions explained via activated cases and feature distances) and manually adjustable by clinicians—and evaluates it through a qualitative interpretative phenomenological analysis (IPA) with 10 licensed mental health practitioners. The study contributes a human-centered evaluation of an inherently interpretable model in a domain where prior XAI work has largely relied on post-hoc methods without interviewing domain experts. The eight extracted themes reveal that clinicians appreciated the model's transparency, adjustability, and potential to integrate clinical expertise, while also raising genuine concerns about bias, training needs, and over-manipulation.

## Strengths

- **Novel and well-motivated qualitative evaluation of XAI in mental health.** Prior surveys (Joyce et al., 2023) confirm that no XAI study in mental health interviewed clinicians about their experience with the models. This paper fills that gap directly by collecting rich, first-hand qualitative data from licensed practitioners—a methodological contribution that goes beyond typical benchmark-driven XAI papers (Section 3.4, lines 119-121).

- **Rich, balanced themes grounded in practitioner quotes.** The eight themes (Section 5.1) capture both enthusiasm (transparency, customization, differential diagnosis potential) and substantive concerns (risk of bias introduction in Theme II, need for guidelines in Theme VII, over-manipulation risk in Theme VIII). The paper does not suppress negative reactions; Theme II explicitly quotes a clinician saying "I didn't quite understand the decision making process" and Theme VIII includes "not sure how accurate the result is." This balanced reporting strengthens credibility.

- **Genuine interpretability-by-design with actionable adjustability.** NN-kNN's architecture (Section 2.2) provides explanations grounded in activated cases and feature distances, with each parameter having a clear semantic role. Unlike post-hoc methods (SHAP, LIME) criticized by Rudin (2019), NN-kNN allows clinicians to manually adjust weights and retrain—a feature that clinicians specifically praised (Theme I: "I can see the whole process regarding coming to the diagnosis"; Theme III: "the tunable feature allows for more tailored diagnostic criteria"). This is a concrete architectural affordance, not just a design aspiration.

- **Rigorous IPA methodology with bias-checking procedures.** The analysis followed a structured four-step IPA process with independent coding by three researchers, discrepancy resolution, and an auditor review (Section 4.4). The team composition (licensed counseling psychologist, doctoral candidate, undergraduate) brings relevant domain expertise.

## Weaknesses

### Fatal
None.

### Major

- **Claims outpace the evidence.** The abstract concludes that NN-kNN has "potential to ethically improve the diagnostic precision and confidence of the practitioner," and the conclusion states the model "enabl[es] practitioners to detect and correct biases." However, the study did not measure diagnostic precision, confidence, or bias correction under controlled conditions—it captured *subjective perceptions* after a single demonstration. While "potential" is hedging, the overall framing (abstract, conclusion, and title) implies a degree of demonstrated clinical utility that a qualitative study of 10 clinicians using a prototype cannot support. This mismatch between claim strength and evidence level is the paper's most significant weakness.

- **Model accuracy is low on a very small dataset, which undermines the relevance of its interpretability in a clinical context.** NN-kNN achieves 0.646 accuracy on 157 samples from a non-clinical (undergraduate) population. The paper acknowledges this ("We urge caution due to the small dataset size and the unstable results," line 137), but the problem is structural: if the model's predictions are wrong ~35% of the time, interpretability of those predictions has limited clinical value. Positive clinician reactions may reflect perceived *potential* rather than actual utility, and the paper does not seriously grapple with whether clinicians would feel differently if the model were deployed with real patients and made frequent errors. The separation of "interpretability" from "predictive performance" (line 128: "Previous work has already examined...prediction performance") is only partially valid—for a diagnostic tool, accuracy and interpretability interact.

### Minor

- **No comparison condition in the user study.** Clinicians were shown only NN-kNN. Their positive reactions could partially reflect general enthusiasm for AI tools, the novelty of any transparent system, or demand characteristics (the interviewers developed the model). Without a comparison to another XAI approach (e.g., SHAP + random forest, a decision tree, or even a non-interpretable baseline), it is impossible to attribute specific responses to NN-kNN's design rather than to generic features of AI systems. This is a common limitation in qualitative studies, but the paper should acknowledge it explicitly rather than implying NN-kNN is uniquely valued.

- **No discussion of data saturation.** With 10 participants, the paper does not justify that thematic saturation was reached, which is standard practice for IPA studies. The paper reports themes were "endorsed by most (at least 6) if not all participants" (line 173), but this does not address whether additional participants would yield new themes.

- **Demonstration format is not standardized.** The model was shown via a Jupyter notebook through Zoom (line 162). How much time each participant spent actively interacting vs. watching a presentation, and how much guidance they received during tuning, is not reported. This makes it difficult to assess how much the interface format (rather than the model itself) shaped the qualitative responses.

- **Researcher-participant power dynamics and bias are not fully addressed.** All three coders were involved in the study design and demonstrations. While bias-checking and auditor review (Section 4.4) mitigate this, the paper does not discuss how participants might have moderated negative feedback when speaking to the model's developers.

### Trivial
None.

## Nice-to-Haves

- A concrete worked example or case study showing how a clinician could use NN-kNN to detect and correct a specific bias in the data or model weights, making the "detect and correct biases" claim tangible.
- A discussion of how the findings might differ with a clinically validated dataset (e.g., PHQ-9 from a clinical population) where the model's accuracy is more reliable.

## Removed Points
These points are flagged to be removed; treat them with caution.

- **Harsh Critic's Structural Issue 1 (central claim unsupported):** The abstract says "potential to ethically improve" and the conclusion describes the model's *capabilities* (what it enables) rather than demonstrated outcomes. The qualitative evidence does show practitioners expressing that the model could improve precision and confidence. The claim is appropriately hedged and the evidence, while perceptual rather than measured, supports it. **Removed because the paper's language is more measured than the critic acknowledges.**

- **Harsh Critic's Section 2.2 vs 4.2 weights discrepancy:** The paper explains in Section 4.2 that "all cases share the same feature weights" for this study. This is a deliberate design simplification, not an inconsistency. The full model allows per-case weights, and the paper is clear about the simplification. **Removed (misunderstands design choice).**

- **Harsh Critic's Section 3.3 claim about connection being "asserted, not demonstrated":** The paper lists challenges in mental health diagnosis to motivate *why* AI tools (broadly) are needed. It does not claim NN-kNN solves all of them. **Removed (overreach / scope creep).**

- **Harsh Critic's comment about the model's "biased" statement being a truism:** The paper's point (line 267) is that transparency is valuable precisely *because* all models are biased—this is a philosophical framing of the contribution, not an empirical claim. **Removed (critic misses the rhetorical purpose).**

- **Strength Finder's Strength 5 (predictive performance as a strength):** Claiming 0.646 accuracy on 157 samples as a strength overstates the significance. The paper itself urges caution. This is moved here because it conflicts with a verified weakness (low accuracy is a real limitation). **Moved for inconsistency with verified weakness.**

- **Strength Finder's Strength 4 (rigorous methodology):** While the IPA process is described, the lack of saturation reporting, potential coder bias, and non-standardized demonstration reduce the rigor claim. The methodology is adequate but not a standout strength. **Moved because the weakness about methodology gaps is more accurate.**

- **Harsh Critic's claim about "selectively amplifies positive comments":** The paper reports 8 themes including explicit concerns (bias risk, need for training, over-manipulation). The critic's own summary acknowledges this. The claim of selective amplification is contradicted by the evidence. **Removed (factually wrong upon verification).**

## Novel Insights

The reviews collectively highlight a tension that the paper does not fully confront: NN-kNN's interpretability is valuable only to the extent that the underlying predictions are trustworthy, yet the paper's evidence of trustworthiness (qualitative affirmation from 10 clinicians) is decoupled from the model's actual predictive reliability. The most novel insight from the reviews is that **interpretability studies with imperfect models may be measuring hope, not utility**—clinicians may react positively to *the idea* of an adjustable model while being unable to judge whether its outputs are clinically sound in practice. This suggests a needed evaluation paradigm: pair qualitative studies with controlled experiments where clinicians use the model on cases with known ground truth, measuring whether interpretability actually improves diagnostic decisions or just makes clinicians feel more confident (potentially dangerously so, if the model is inaccurate). The paper's data (Theme II, Theme VIII) already hints at this risk, but the analysis does not center it.

## Suggestions

1. **Narrow the claims to match the evidence.** Re-frame the abstract and conclusion to say the study provides preliminary qualitative evidence that clinicians *perceive* NN-kNN as having potential for improving diagnostic transparency and confidence, rather than claiming the model *achieves* these outcomes.

2. **Add a controlled user study as the next step.** A within-subjects design comparing NN-kNN to a post-hoc XAI method (e.g., SHAP + random forest) on a realistic diagnostic task would directly address the most serious weakness: attributing effects to NN-kNN specifically. Measure diagnostic accuracy, confidence calibration, and time-to-decision.

3. **Retire the model or re-scope.** If the paper is about interpretability, train NN-kNN on a larger, clinically validated dataset (e.g., PHQ-9 responses from a clinical population, or any dataset where accuracy is >0.8) before running user studies. The current dataset's size and accuracy floor the clinical relevance of any subsequent evaluation.

4. **Add a saturation analysis and acknowledge demographic limits.** Report a saturation curve or cite relevant IPA sample-size guidelines. Explicitly note that the US-only, mostly female sample limits generalizability.

5. **Include a concrete bias-detection case study.** Show a real or constructed example where NN-kNN's case activations and feature weights reveal a problematic data bias (e.g., a feature that correlates with depression only because of a confound), and trace how a clinician could detect and correct it.

## Score and Decision

The paper addresses a genuine gap (qualitative evaluation of interpretable AI with clinicians), and the IPA study is competently conducted with balanced reporting of both positive and skeptical reactions. However, the paper's contribution is fundamentally bounded by (a) claims that slightly outpace what a qualitative study of 10 participants on a low-accuracy model can support, and (b) the absence of any comparative or controlled evidence that NN-kNN's specific design is responsible for the observed responses. The model's poor accuracy on a tiny dataset also weakens the clinical relevance of the interpretability findings. These are not fatal flaws—this is a reasonable preliminary exploration—but they prevent the paper from supporting a strong acceptance decision at a competitive venue.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>